Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Neuhaus

Showing results (431-440 of 440) with videos related to

Pageof 44
Sort By:
You have reached the last page of results.This site can display upto 440 results.
Hepatology (Baltimore, Md.)|December 3, 2003
Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patientsEugene R Schiff, Ching-Lung Lai, Stefanos Hadziyannis, et al.
Lancet (London, England)|January 24, 2006
3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcomeAndrew K Burroughs, Caroline A Sabin, Keith Rolles, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 8, 2010
Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European Liver Transplant RegistryChristoph Schramm, Michael Bubenheim, René Adam, et al.
Frontiers in Oncology|November 4, 2022
Feasibility and Efficacy of Adjuvant Chemotherapy With Gemcitabine After Liver Transplantation for Perihilar Cholangiocarcinoma - A Multi-Center, Randomized, Controlled Trial (pro-duct001)Moritz Schmelzle, Christian Benzing, Lutz Fischer, et al.
The Lancet. Oncology|December 9, 2008
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysisVincenzo Mazzaferro, Josep M Llovet, Rosalba Miceli, et al.
Nature Medicine|February 9, 2016
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinomaElisa M Noll, Christian Eisen, Albrecht Stenzinger, et al.
Ecology Letters|May 1, 2008
Senescence rates are determined by ranking on the fast-slow life-history continuumOwen R Jones, Jean-Michel Gaillard, Shripad Tuljapurkar, et al.
Annals of Surgery|September 5, 2020
mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active TumorsAndreas A Schnitzbauer, Natalie Filmann, René Adam, et al.
BMC Cancer|May 13, 2010
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinomaAndreas A Schnitzbauer, Carl Zuelke, Christian Graeb, et al.
Transplantation|November 12, 2015
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 TrialEdward K Geissler, Andreas A Schnitzbauer, Carl Zülke, et al.
Pageof 44

Showing results (431-440 of 440) with videos related to

Sort By:
Pageof 44
You have reached the last page of results.This site can display upto 440 results.
Hepatology (Baltimore, Md.)|December 3, 2003
Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patientsEugene R Schiff, Ching-Lung Lai, Stefanos Hadziyannis, et al.
Lancet (London, England)|January 24, 2006
3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcomeAndrew K Burroughs, Caroline A Sabin, Keith Rolles, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 8, 2010
Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European Liver Transplant RegistryChristoph Schramm, Michael Bubenheim, René Adam, et al.
Frontiers in Oncology|November 4, 2022
Feasibility and Efficacy of Adjuvant Chemotherapy With Gemcitabine After Liver Transplantation for Perihilar Cholangiocarcinoma - A Multi-Center, Randomized, Controlled Trial (pro-duct001)Moritz Schmelzle, Christian Benzing, Lutz Fischer, et al.
The Lancet. Oncology|December 9, 2008
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysisVincenzo Mazzaferro, Josep M Llovet, Rosalba Miceli, et al.
Nature Medicine|February 9, 2016
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinomaElisa M Noll, Christian Eisen, Albrecht Stenzinger, et al.
Ecology Letters|May 1, 2008
Senescence rates are determined by ranking on the fast-slow life-history continuumOwen R Jones, Jean-Michel Gaillard, Shripad Tuljapurkar, et al.
Annals of Surgery|September 5, 2020
mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active TumorsAndreas A Schnitzbauer, Natalie Filmann, René Adam, et al.
BMC Cancer|May 13, 2010
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinomaAndreas A Schnitzbauer, Carl Zuelke, Christian Graeb, et al.
Transplantation|November 12, 2015
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 TrialEdward K Geissler, Andreas A Schnitzbauer, Carl Zülke, et al.
Pageof 44